Titre :
  • Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.
Auteur : Hoskins, P ; Vergote, Ignace ; Cervantes, Andrés ; Tu, Dongsheng ; Stuart, G ; Zola, Paolo ; Poveda, Andrés ; Provencher, D ; Katsaros, D ; Ojeda, B ; Ghatage, P ; Grimshaw, Rachel ; Casado, M. ; Elit, L ; Mendiola, César ; Sugimoto, A ; D'Hondt, Veronique ; Ozaita, Andrés ; Germa, J R ; Roy, M ; Brotto, L ; Chen, Dan ; Eisenhauer, Elizabeth
Informations sur la publication : Journal of the National Cancer Institute, 102, 20, (page 1547-1556)
Statut de publication : Publié, 2010-10
Sujet CREF : Cancérologie
Mots-clés MeSH : Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Carboplatin -- administration & dosage
Carcinoma -- drug therapy -- secondary
Cisplatin -- administration & dosage -- adverse effects
Disease-Free Survival
Drug Administration Schedule
Drug Resistance, Neoplasm
Female
Humans
Middle Aged
Neoplasm Staging
Odds Ratio
Ovarian Neoplasms -- drug therapy -- pathology
Paclitaxel -- administration & dosage
Topotecan -- administration & dosage -- adverse effects
Treatment Failure
Note : Clinical Trial, Phase III
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0027-8874 
info:doi/10.1093/jnci/djq362
info:pii/djq362
info:pmid/20937992